OIS
TEVA icon

Okabena Investment Services’s Teva Pharmaceuticals TEVA Stock Holding History

Okabena Investment Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,518
Closed -$708K – 157
2026
Q1 		$708K Buy
+23,518
New +$757K 0.14% 95
2025
Q3 		– Sell
-31,944
Closed -$535K – 145
2025
Q2 		$535K Buy
31,944
+1,703
+6% +$27.5K 0.12% 97
2025
Q1 		$465K Sell
30,241
-6,209
-17% -$111K 0.12% 100
2024
Q4 		$803K Sell
36,450
-22,326
-38% -$406K 0.22% 73
2024
Q3 		$1.06M Buy
+58,776
New +$1.03M 0.3% 62

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Okabena Investment Services's TEVA Position: Q2 2026 in Review

Okabena Investment Services sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 23,518 shares — an estimated $708K sold.

Okabena Investment Services first reported a position in TEVA in Q3 2024 and held it in 5 quarters. The position peaked at $1.06M in Q3 2024. 451 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Okabena Investment Services reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Okabena Investment Services sold 23,518 Teva Pharmaceuticals shares in Q2 2026, an estimated $708K.
  • Okabena Investment Services first reported a position in Teva Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Okabena Investment Services's Teva Pharmaceuticals position peaked at $1.06M in Q3 2024.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Okabena Investment Services's 13F filing for Q2 2026, filed 4 Aug 2026.